CIK: 1775490 - Address: C/O Applied Therapeutics, Inc., 545 Fifth Avenue, Suite 1400, New York, NY 10017
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/14/24 19:01
8/12/24
APLTApplied Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOP,CEOS.m-4,7126.060-777-107,309M
6/10/24 16:29
6/6/24
APLTApplied Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOS-2674.320-62-18,087D
3/18/24 18:12
3/14/24
APLTApplied Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOS-1,7175.390-319-48,148D
12/1/23 19:42
11/30/23
APLTApplied Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOS-81.970-406,927D
9/29/23 20:03
9/27/23
APLTApplied Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOS-3122.700-116-26,931D
1/13/23 16:34
1/11/23
APLTApplied Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOS-140.91000-1607,046D
10/14/22 17:41
10/14/22
APLTApplied Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOP320.645005015,098D
10/13/22 18:17
10/13/22
APLTApplied Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOP410.558207315,048D
10/12/22 20:51
10/12/22
APLTApplied Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsShendelman ShoshanaNYDOTP,CEOP200.522703814,975D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact